Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

“GLP-1 receptor agonists are popular due to their dual benefits in improving glycemic control for Type 2 diabetes and promoting significant weight loss,” Vukasinov explained. These medications ...

The family of medications called GLP-1 receptor agonists includes ... They can also help type 1 diabetes patients lose weight, something that’s especially difficult for people who take insulin ...

For those with insulin resistance, diabetes, or PCOS, adding more GLP-1 can help spur the process along. The benefits of GLP-1 drugs extend beyond weight loss. "There are cardiovascular benefits ...

Iuliia Burmistrova/Getty Images GLP-1 drugs have helped people successfully achieve and maintain weight loss ... received approval for treating type 2 diabetes and/or obesity.

That doesn't seem like a lot, amounting to an estimated 854,000 Americans without diabetes using GLP-1 drugs to lose weight in 2022, but the drugs are costly, and can run close to $1,000 or more a ...